aXichem and Canadian based Iovate sign Letter of Intent regarding development and commercialization of aXivite, as ingredient in weight management supplement
aXichem AB (publ), that develops and markets natural analogue industrial compounds, has signed a Letter of Intent (LOI) with the Canadianbased company Iovate Health Sciences International Inc. (Iovate). The purpose of the LOI is to summarize the basic terms of an agreement regarding joint research, development and commercialization of a product for weight management, containing aXichem’s capsaicin analogue product, aXivite, as ingredient. The agreement also aims to provide Iovate with an exclusive license to sell the new product on the U.S. market. Iovate is one of the world’s leading